- J&J proposes $5.5B talc settlementAfter more than a decade and three failed bankruptcy attempts, an end to Johnson & Johnson’s talc saga may finally be in sight. The company has proposed a $5.5 billion settlement ...
- Oak Hill Bio merges with RA Capital SPAC; InnoCare's TYK2 drug hits in Phase 3💵 Oak Hill Bio’s SPAC merger: The Angelman syndrome biotech will merge with RA Capital’s blank-check company, called Research Alliance Corporation III, and get about ...